Myovant Sciences Ltd. (MYOV) Reaches $23.25 After 7.00% Up Move; Teleflex (TFX) Had 8 Analysts Last Week

April 17, 2018 - By Nellie Frank

Teleflex Incorporated (NYSE:TFX) Logo

Among 12 analysts covering Teleflex (NYSE:TFX), 8 have Buy rating, 0 Sell and 4 Hold. Therefore 67% are positive. Teleflex had 35 analyst reports since July 31, 2015 according to SRatingsIntel. Raymond James upgraded the stock to “Strong Buy” rating in Wednesday, January 6 report. The firm earned “Hold” rating on Tuesday, September 5 by KeyBanc Capital Markets. The stock of Teleflex Incorporated (NYSE:TFX) has “Hold” rating given on Tuesday, November 14 by Deutsche Bank. The rating was upgraded by Jefferies to “Buy” on Friday, January 6. The company was maintained on Tuesday, January 30 by Leerink Swann. Leerink Swann maintained it with “Outperform” rating and $300 target in Friday, February 23 report. As per Friday, August 4, the company rating was maintained by Needham. The rating was maintained by Stephens with “Buy” on Wednesday, January 17. Needham maintained Teleflex Incorporated (NYSE:TFX) rating on Tuesday, September 5. Needham has “Buy” rating and $237.0 target. The stock of Teleflex Incorporated (NYSE:TFX) has “Hold” rating given on Thursday, October 12 by KeyBanc Capital Markets. See Teleflex Incorporated (NYSE:TFX) latest ratings:

04/04/2018 Broker: Goldman Sachs Rating: Neutral New Target: $257 Initiates Coverage On
22/02/2018 Broker: Jefferies Rating: Buy New Target: $290.0 Maintain
23/02/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $321 New Target: $300 Maintain
30/01/2018 Broker: Leerink Swann Rating: Buy New Target: $321.0 Maintain
17/01/2018 Broker: Stephens Rating: Buy New Target: $300.0 Maintain
18/12/2017 Broker: Raymond James Rating: Buy New Target: $300.0
16/11/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
14/11/2017 Broker: Deutsche Bank Old Rating: Buy New Rating: Hold Downgrade
10/11/2017 Broker: Piper Jaffray Rating: Buy New Target: $295.0 Initiate
03/11/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $274 New Target: $290 Maintain

The stock of Myovant Sciences Ltd. (NYSE:MYOV) is a huge mover today! The stock increased 6.31% or $1.38 during the last trading session, reaching $23.25. About 296,554 shares traded or 282.54% up from the average. Myovant Sciences Ltd. (NYSE:MYOV) has risen 79.46% since April 17, 2017 and is uptrending. It has outperformed by 67.91% the S&P500.The move comes after 6 months positive chart setup for the $1.44B company. It was reported on Apr, 17 by Barchart.com. We have $24.88 PT which if reached, will make NYSE:MYOV worth $101.08M more.

Teleflex Incorporated designs, develops, makes, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company has market cap of $12.02 billion. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. It has a 80.89 P/E ratio. The firm also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands.

Since January 2, 2018, it had 0 insider purchases, and 11 selling transactions for $7.36 million activity. On Tuesday, February 27 Deren John sold $347,449 worth of Teleflex Incorporated (NYSE:TFX) or 1,359 shares. Shares for $707,775 were sold by BABICH GEORGE JR. $55,288 worth of Teleflex Incorporated (NYSE:TFX) was sold by Klasko Stephen K. M.D.. $2.35M worth of Teleflex Incorporated (NYSE:TFX) was sold by SMITH BENSON on Monday, April 2.

The stock increased 0.79% or $2.07 during the last trading session, reaching $264.59. About 110,867 shares traded. Teleflex Incorporated (NYSE:TFX) has risen 32.04% since April 17, 2017 and is uptrending. It has outperformed by 20.49% the S&P500.

Investors sentiment increased to 1.13 in 2017 Q4. Its up 0.03, from 1.1 in 2017Q3. It increased, as 19 investors sold Teleflex Incorporated shares while 132 reduced holdings. 62 funds opened positions while 108 raised stakes. 39.40 million shares or 0.28% more from 39.29 million shares in 2017Q3 were reported. Commonwealth Of Pennsylvania Public School Empls Retrmt has invested 0.02% in Teleflex Incorporated (NYSE:TFX). 5,548 are held by Advantus Capital. Riverhead Capital Lc owns 9,343 shares or 0.1% of their US portfolio. Creative Planning holds 4,119 shares or 0% of its portfolio. Commonwealth Bancorporation Of invested 0% of its portfolio in Teleflex Incorporated (NYSE:TFX). Rodgers Brothers Inc accumulated 4,251 shares. Fairview Capital Mngmt Ltd Liability Corp has invested 2.94% of its portfolio in Teleflex Incorporated (NYSE:TFX). Bahl Gaynor owns 52,919 shares for 0.14% of their portfolio. City Hldgs Com reported 42 shares stake. Amp Cap Investors Limited stated it has 0.05% of its portfolio in Teleflex Incorporated (NYSE:TFX). Select Equity Group Limited Partnership has invested 3.52% in Teleflex Incorporated (NYSE:TFX). Art Advisors invested in 0.04% or 3,300 shares. Castleark Mngmt Limited Liability Com owns 24,980 shares or 0.19% of their US portfolio. Veritable Limited Partnership owns 5,996 shares. World Asset invested in 2,783 shares.

Teleflex Incorporated (NYSE:TFX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>